Effect of anaesthesia maintained with sevoflurane and propofol on surgical site infection after elective open gastrointestinal surgery

Journal of Hospital Infection

Volumn 74, Issue 2, 2010, Pages 129-136

  Shimizu, K ^a   Hirose, M ^a   Mikami, S ^a   Takamura, K ^a   Goi, T ^a   Yamaguchi, A ^a   Morioka, K ^a   Ichikawa, T ^b   Shigemi, K ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b Niigata Prefectural Muikamachi Hospital   (Japan)

Author keywords

Gastrointestinal surgery; Sevoflurane; Surgical site infection

Indexed keywords

PROPOFOL; SEVOFLURANE;

AGED; ARTICLE; COLON SURGERY; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; GASTROINTESTINAL SURGERY; GENERAL ANESTHESIA; HUMAN; INFECTION RATE; INFECTION RISK; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; OXYGEN CONCENTRATION; STOMACH SURGERY; SURGICAL INFECTION;

AGED; AGED, 80 AND OVER; ANESTHESIA; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; PROPOFOL; SURGICAL WOUND INFECTION;

EID: 74749105722     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.10.011     Document Type: Article

References (40)

1. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., and Jarvis W.R. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 20 (1999) 247-278
2. Cheadle W.G. Risk factors for surgical site infection. Surg Infect 7 Suppl. 3 (2006) S7-S11
3. Yoshida M., Nabeshima T., Gomi H., and Lefor A.T. Technology and the prevention of surgical site infections. J Surg Educ 64 (2007) 302-309
4. Homer-Vanniasinkam S. Surgical site and vascular infections: treatment and prophylaxis. Int J Infect Dis 11 Suppl. 1 (2007) S17-S22
5. Sørensen L.T., Hemmingsen U., Kallehave F., et al. Risk factors for tissue and wound complications in gastrointestinal surgery. Ann Surg 241 (2005) 654-658
6. de Oliveira A.C., Ciosak S.I., Ferraz E.M., and Grinbaum R.S. Surgical site infection in patients submitted to digestive surgery: risk prediction and the NNIS risk index. Am J Infect Control 34 (2006) 201-207
7. Watanabe A., Kohnoe S., Shimabukuro R., et al. Risk factors associated with surgical site infections in upper and lower gastrointestinal surgery. Surg Today 38 (2008) 404-412
8. Sessler D.I. Non-pharmacologic prevention of surgical wound infection. Anesthesiol Clin 24 (2006) 279-297
9. Mauermann W.J., and Nemergut E.C. The anesthesiologist's role in the prevention of surgical site infections. Anesthesiology 105 (2006) 413-421
10. Benhaim P., and Hunt T.K. Natural resistance to infection: leukocyte functions. J Burn Care Rehabil 13 (1992) 287-292
11. Qadan M., Akca O., Mahid S.S., Hornung C.A., and Polk Jr. H.C. Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials. Arch Surg 144 (2009) 359-366
12. Allaouchiche B., Debon R., Goudable J., Chassard D., and Duflo F. Oxidative stress status during exposure to propofol, sevoflurane and desflurane. Anesth Analg 93 (2001) 981-985
13. Rodríguez-López J.M., Sánchez-Conde P., Lozano F.S., et al. Laboratory investigation: effects of propofol on the systemic inflammatory response during aortic surgery. Can J Anaesth 53 (2006) 701-710
14. Cinnella G., Vendemiale G., Dambrosio M., et al. Effect of propofol, sevoflurane and desflurane on systemic redox balance. Int J Immunopathol Pharmacol 20 (2007) 585-593
15. Arnaoutoglou H., Vretzakis G., Souliotis D., Cambili M., Galaris D., and Papadopoulos G. The effects of propofol or sevoflurane on free radical production after tourniquet induced ischaemia-reperfusion injury during knee arthroplasty. Acta Anaesthesiol Belg 58 (2007) 3-6
16. Tsuchiya M., Sato E.F., Inoue M., and Asada A. Open abdominal surgery increases intraoperative oxidative stress: can it be prevented?. Anesth Analg 107 (2008) 1946-1952
17. Huenger F., Schmachtenberg A., Haefner H., et al. Evaluation of postdischarge surveillance of surgical site infections after total hip and knee arthroplasty. Am J Infect Control 33 (2005) 455-462
18. Yoshida J., Shinohara M., Ishikawa M., and Matsuo K. Surgical site infection in general and thoracic surgery: surveillance of 2663 cases in Japanese teaching hospital. Surg Today 36 (2006) 114-118
19. Gaynes R.P., Culver D.H., Horan T.C., Edwards J.R., Richards C., Tolson J.S., and National Nosocomial Infections Surveillance System. Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System Basic SSI Risk Index. Clin Infect Dis 33 Suppl. 2 (2001) S69-S77
20. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
21. Kobayashi T., Robinson J.M., and Seguchi H. Identification of intracellular sites of superoxide production in stimulated neutrophils. J Cell Sci 111 (1998) 81-91
22. Roos D., van Bruggen R., and Meischl C. Oxidative killing of microbes by neutrophils. Microbes Infect 5 (2003) 1307-1315
23. Robinson J.M. Reactive oxygen species in phagocytic leukocytes. Histochem Cell Biol 130 (2008) 281-297
24. Hopf H.W., and Rollins M.D. Wounds: an overview of the role of oxygen. Antioxid Redox Signal 9 (2007) 1183-1192
25. Wong C.H., Liu T.-Z., Chye S.-M., et al. Sevoflurane-induced oxidative stress and cellular injury in human peripheral polymorphonuclear neutrophils. Food Chem Toxicol 44 (2006) 1399-1407
26. Murphy P.G., Myers D.S., Davies M.J., Webster N.R., and Jones J.G. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 68 (1992) 613-618
27. Kahraman S., and Demiryürek A.T. Propofol is a peroxynitrite scavenger. Anesth Analg 84 (1997) 1127-1129
28. Ansley D.M., Lee J., Godin D.V., Garnett M.E., and Qayumi A.K. Propofol enhances red cell antioxidant capacity in swine and humans. Can J Anaesth 45 (1998) 233-239
29. Kobayashi K., Yoshino F., Takahashi S., et al. Direct assessments of the antioxidant effects of propofol medium chain triglyceride/long chain triglyceride on the brain of stroke-prone spontaneously hypertensive rats using electron spin resonance spectroscopy. Anesthesiology 109 (2008) 426-435
30. Fröhlich D., Rothe G., Schwall B., et al. Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP. Br J Anaesth 78 (1997) 718-723
31. Tyther R., O'Brien J., Wang J., Redmond H.P., and Shorten G. Effect of sevoflurane on human neutrophil apoptosis. Eur J Anaesthesiol 20 (2003) 111-115
32. Schneemilch C.E., Hachenberg T., Ansorge S., Ittenson A., and Bank U. Effects of different anaesthesic agents on immune cell function in vitro. Eur J Anaesthesiol 22 (2005) 616-623
33. Loop T., Dovi-Akue D., Frick M., et al. Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. Anesthesiology 102 (2005) 1147-1157
34. Chen R.-M., Wu C.-H., Chang H.-C., et al. Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis. Anesthesiology 98 (2003) 1178-1185
35. Kurosawa S., and Kato M. Anesthetics, immune cells, and immune responses. J Anesth 22 (2008) 263-277
36. Ogata M., Tutumimoto-Sato K., Kunikane T., et al. Antibacterial activity of dipropofol and related compounds. Biol Pharm Bull 28 (2005) 1120-1122
37. Karabiyik L., Türkan H., Özişik T., Saraçli M.A., and Haznedaroǧlu T. Effects of sevoflurane and/or nitrous oxide on bacterial growth in in vitro culture conditions. J Anesth 21 (2007) 436-438
38. Roumbelaki M., Kritsotakis E.I., Tsioutis C., Tzilepi P., and Gikas A. Surveillance of surgical site infections at a tertiary care hospital in Greece: incidence, risk factors, microbiology, and impact. Am J Infect Control 36 (2008) 732-738
39. Greif R., Akca O., Horn E.-P., Kurz A., and Sessler D.I. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 342 (2000) 161-167
40. Belda F.J., Aguilera L., de la Asuncion J.G., et al. Supplemental perioperative oxygen and the risk of surgical wound infection. J Am Med Assoc 294 (2005) 2035-2042